Literature DB >> 29105027

Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.

Naveen Pemmaraju1, Audun Utengen2, Vikas Gupta3, Jean-Jacques Kiladjian4, Ruben Mesa5, Michael A Thompson6.   

Abstract

PURPOSE OF REVIEW: The use of social media has now become a standard means of communication for many individuals worldwide. The use of one specific form of social media, Twitter, has increased among healthcare providers, both as a means of information gathering and as a conduit for original content creation. Recently, major efforts by users have been put forward to help streamline the unprecedented amount of information that can be found on Twitter. These efforts have led to the creation of diseasespecific hashtag (#) medical communities and have greatly enhanced the ability to understand and better categorize the available data on Twitter. Specifically, for those involved in rare cancer fields, adhering to organically designed and consistently used hashtags has led to the rapid, reliable dissemination of information and the ability to efficiently discuss and debate topics of interest in the field. For the field of myeloproliferative neoplasms (MPNs), the creation of #MPNSM (myeloproliferative neoplasms on social media) in 2015 has facilitated interactions among healthcare stakeholders from all over the world in the MPN field. RECENT
FINDINGS: In order to better understand the trends and topics of interest to Twitter users of this novel medical community, we conducted the present analysis which focuses on Twitter analytics from the first two years of #MPNSM. In this analysis, we observed a sustained increase in the number of Twitter users, number of tweets, number of impressions, and number of retweets over time, demonstrating the feasibility of creating and maintaining a disease-specific hashtag for a rare cancer over time.

Entities:  

Keywords:  Disease-specific hashtag; Essential thrombocytosis; MPN; Myelofibrosis; Myeloproliferative neoplasm; Polycythemia vera; Social media; Twitter

Mesh:

Year:  2017        PMID: 29105027      PMCID: PMC8148890          DOI: 10.1007/s11899-017-0421-y

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  11 in total

1.  Scientists in the Twitterverse.

Authors:  Neil Savage
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

2.  The emerging role of professional social media use in oncology.

Authors:  Mina S Sedrak; Don S Dizon; Patricia F Anderson; Michael J Fisch; David L Graham; Matthew S Katz; Jennifer C Kesselheim; Robert S Miller; Michael A Thompson; Audun Utengen; Deanna J Attai
Journal:  Future Oncol       Date:  2017-06-07       Impact factor: 3.404

3.  Using social media in oncology for education and patient engagement.

Authors:  Michael A Thompson; Anas Younes; Robert S Miller
Journal:  Oncology (Williston Park)       Date:  2012-09       Impact factor: 2.990

Review 4.  Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Authors:  Naveen Pemmaraju; Vikas Gupta; Michael A Thompson; Andrew A Lane
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

5.  Cancer Communication in the Social Media Age.

Authors:  Mina S Sedrak; Roger B Cohen; Raina M Merchant; Marilyn M Schapira
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

Review 6.  Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer.

Authors:  Miguel-Angel Perales; Emily K Drake; Naveen Pemmaraju; William A Wood
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

Review 7.  Social Media and Myeloproliferative Neoplasms (MPN)--Focus on Twitter and the Development of a Disease-specific Community: #MPNSM.

Authors:  Naveen Pemmaraju; Vikas Gupta; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 8.  Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider.

Authors:  Michael A Thompson; Navneet S Majhail; William A Wood; Miguel-Angel Perales; Mélanie Chaboissier
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

9.  Ten simple rules of live tweeting at scientific conferences.

Authors:  Sean Ekins; Ethan O Perlstein
Journal:  PLoS Comput Biol       Date:  2014-08-21       Impact factor: 4.475

10.  Twitter as a Potential Data Source for Cardiovascular Disease Research.

Authors:  Lauren Sinnenberg; Christie L DiSilvestro; Christina Mancheno; Karl Dailey; Christopher Tufts; Alison M Buttenheim; Fran Barg; Lyle Ungar; H Schwartz; Dana Brown; David A Asch; Raina M Merchant
Journal:  JAMA Cardiol       Date:  2016-12-01       Impact factor: 14.676

View more
  9 in total

Review 1.  Social Media and Hematopoietic Cell Transplantation: a Review of Online Resources and Communities.

Authors:  Sagar S Patel; Navneet S Majhail
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

2.  Patient preferences and comfort for cancer survivorship models of care: results of an online survey.

Authors:  Deanna J Attai; Matthew S Katz; Elani Streja; Jui-Ting Hsiung; Maria V Marroquin; Beverly A Zavaleta; Larissa Nekhlyudov
Journal:  J Cancer Surviv       Date:  2022-02-03       Impact factor: 4.442

3.  Communication strategies for rare cancers: a systematic review protocol.

Authors:  Catherine Bell; Katie Kerr; Kerry Moore; Charlene McShane; Lesley Anderson; Amy Jayne McKnight; Helen McAneney
Journal:  Syst Rev       Date:  2019-04-23

Review 4.  Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges.

Authors:  Jessica S Little; Rizwan Romee
Journal:  Curr Hematol Malig Rep       Date:  2020-11-11       Impact factor: 3.952

5.  Conversations and Misconceptions About Chemotherapy in Arabic Tweets: Content Analysis.

Authors:  Abdulrahman Alghamdi; Khalid Abumelha; Jawad Allarakia; Ahmed Al-Shehri
Journal:  J Med Internet Res       Date:  2020-07-29       Impact factor: 5.428

6.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

7.  Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease.

Authors:  Ben L Da; Pallavi Surana; Samuel A Schueler; Niloofar Y Jalaly; Natasha Kamal; Sonia Taneja; Anusha Vittal; Christy L Gilman; Theo Heller; Christopher Koh
Journal:  Hepatol Commun       Date:  2019-07-13

8.  Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience.

Authors:  Siba El Hussein; Joseph D Khoury; Kirill A Lyapichev; Mehrnoosh Tashakori; Mahsa Khanlari; Roberto N Miranda; Rashmi Kanagal-Shamanna; Sa A Wang; Aadil Ahmed; Kamran M Mirza; Genevieve M Crane; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Mod Pathol       Date:  2020-11-20       Impact factor: 7.842

Review 9.  Current Status of Genetic Counselling for Rare Diseases in Spain.

Authors:  Sara Álvaro-Sánchez; Irene Abreu-Rodríguez; Anna Abulí; Clara Serra-Juhe; Maria Del Carmen Garrido-Navas
Journal:  Diagnostics (Basel)       Date:  2021-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.